Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
Limited Coverage Drugs - Special Authority Criteria

Generic Name / Strength / Form
entecavir 0.5mg tablet

Criteria Approval Period
Diagnosis of chronic Hepatitis B

PLUS

Provide histologic or radiologic evidence of cirrhosis
OR
Provide other evidence of portal hypertension

PLUS

Lab work required as per the Chronic Hepatitis B form.

First approval: One year

Renewals: One year, only if patient demonstrates a positive response to treatment.

All requests to be submitted on the Chronic Hepatitis B form.
See form link below.

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • Coverage for entecavir for chronic Hepatitis B becomes effective March 27, 2008.

Form

Chronic Hepatitis B - Initial and Renewal Coverage (PDF)
Click on the link to complete a special authority request form.



PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Back To Top

Last Revised: March 25, 2008

blank
    space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank
    space for alignment blank space for alignment blank space for alignment blank space for alignment